A protocol nobody measured is a protocol nobody repeats.
Regenerative medicine sells an intervention and then asks the patient to report how they feel. A baseline panel and a re-test at ninety days replace that with a number — which is what turns one treatment into a programme.
Buy ten or more of any SKU and we match it on consignment — invoiced at your next order, less your profit.
Economics shown on the General Wellness panel. Every panel in the catalogue works the same way.
Measurement is the product. The protocol is what you already sell.
This is the vertical where a diagnostic changes the business model rather than adding a line to it.
Baseline and the ninety-day re-test. The second one is where compliance and retention actually come from.
Clinically indicated, not calendar-driven. We will not print a re-test schedule as though a guideline required it.
Your opening order on the diagnostic line, yours once bought.
A re-test shows that a marker moved. It does not prove the protocol caused it, and it is not the same as a clinical outcome. We will not supply material that implies otherwise, and that discipline is what lets you use the number in front of a sceptical patient at all.
Start with one. Stack the second.
We recommend a lead panel from your patient mix rather than from our margin. These are the two that fit this room.
Before a regenerative protocol, this is the metabolic and hormonal starting point — and after it, the same panel is the only honest way to show anything changed. It is also the panel that identifies the patient for whom the answer is weight, sleep or thyroid rather than the protocol you were about to sell.
It is not a TRT diagnostic on its own. Men's health clinics should ask about the reconfigured TRT Baseline build, which adds PSA, LH, FSH, SHBG, calculated free testosterone and reflexed prolactin.
For practices running a longevity programme, StemAge is the regenerative-age panel. The analyte list and the price are now published — inflammation, mitochondrial and oxidative stress, metabolic, immune, detoxification and hormones, read against the patient’s own baseline rather than a biological-age score.
It does not diagnose anything, and it does not measure a biological age with an established clinical cut-point. It is a panel of functional markers read against the patient’s own baseline, which is why it is sold as a before-and-after pair rather than a single score.
Stack the rest.
The same patients buy the rest of the catalogue, and every panel is bought on the same terms. Adding one adds a revenue line without adding space or chair time — and a second panel collected on the same visit costs the same chair time as the first.
You buy it. You price it. You keep the difference.
Populate the table with your own volume — these are our assumptions, not your numbers.
| New protocol starts / month | Panels (baseline + re-test) | You keep each | Monthly | Annual |
|---|---|---|---|---|
| 5 starts | 10 | $200 | $2,000 | $24,000 |
| 10 starts | 20 | $200 | $4,000 | $48,000 |
| 20 starts | 40 | $200 | $8,000 | $96,000 |
Two panels per protocol start — the baseline and the ninety-day re-test. StemAge margin is quoted separately per account. Peptide and regenerative product margin sits on top of this and is bought on the same terms.
Baseline. Treat. Prove it moved.
The panel is what makes everything else you sell repeatable, and it creates a second high-value visit per cycle.
Baseline
A panel establishes status before anything is prescribed.
Visit oneIntervention
Your protocol as today, plus whatever the panel indicated. That decision is yours, not ours.
Your protocolRe-test when indicated
A clinically indicated re-test shows what moved — and gives the patient a reason to come back and see it.
Visit twoShow the patient what it is
Three clips per panel, sized for a waiting-room screen or a social post. Download them from the poster page along with the print files.
The General Wellness box exactly as it arrives. The artwork is the real print file, not a rendering of it.
What the General Wellness panel measures and how the sample is collected.
A patient being handed the General Wellness kit in a clinic. Closes on the box itself.
The StemAge box exactly as it arrives. The artwork is the real print file, not a rendering of it.
What the StemAge panel measures and how the sample is collected.
A patient being handed the StemAge kit in a clinic. Closes on the box itself.
A poster for the waiting room.
Typeset, not AI-generated — so the text is correct and the claims match the standards page. A4 and US Letter for print, plus a square crop for social.
Your practice name can be added to the footer of any poster — send it with your application and we will supply a personalised set.
What you will ask first
Including the ones where the honest answer costs us the sale.
Do you supply the regenerative products too?
Yes — UCT-MSCs and lineage-specific exosome matrices, cGMP, strict P1/P2 maximum, DMSO-free, COA every lot, made in the USA. They are bought normally at clinic pricing, outside the panel match promotion, and they go to licensed providers only.
What is StemAge actually measuring?
Six marker groups: inflammation (IL-6, TNF-alpha, CRP, ESR, IL-1β, fibrinogen), mitochondrial and oxidative stress (NAD+/NADH, ATP production, 8-OHdG, GSH:GSSG), metabolic (HOMA-IR, OGTT, fasting insulin, triglyceride:HDL), immune (CD4/CD8, Treg/Th17, NK activity, IgG subclasses), detoxification and environmental load, and hormones (cortisol AM/PM, DHEA-S, TSH, FT3, FT4, rT3, sex hormones). It does not report a biological age, because those scores carry no established clinical cut-point — it is read against the patient’s own first draw.
Can we claim the protocol reversed biological age?
No, and we will not supply material that does. A marker moved. That is the claim, and it is a strong one when it is true.
Is any of this FDA-cleared?
No panel here is cleared or approved by the FDA for the indications described. Regenerative products carry no indication claim — we supply the product, the COA and the protocol reference; the clinical decision and the consent are yours.
What arrives
- Your opening order — buy ten or more and we match it
- One virtual training session for your team
- Provider portal access for results
- The CLIA certificate number and named assay methods
- Print-ready posters and the waiting-room video files
Panels are laboratory-developed tests performed by a CLIA-certified laboratory. They are not FDA-cleared for the indications described and do not diagnose, stage or grade disease. Economics shown are illustrative and not a guarantee of results.